Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

Share Price is delayed by 15 minutes
Get Live Data
98.60    0.60 (0.61%)
Bid:
98.50
Ask:
98.65
Spread: 0.15 (0.152%)
Market Cap: £1.56b
SRE Live PriceLast checked at - London Stock Exchange

Intraday Sirius Real Estate Share Chart

Board Changes

28 May 2024 07:00

RNS Number : 9543P
Sirius Real Estate Limited
28 May 2024
 

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (GBP) Share Code: SRE

LEI: 213800NURUF5W8QSK566

ISIN Code: GG00B1W3VF54

 

28 May 2024

Sirius Real Estate Limited

("Sirius Real Estate" or the "Company")

Board Changes

Sirius Real Estate, the leading operator of branded business and industrial parks providing conventional space and flexible workspace in Germany and the UK, announces that James Peggie will step down as an independent non-executive director of the Company at the conclusion of the upcoming annual general meeting in June 2024 ("2024 AGM") and that Deborah Davis will join the Company's Board as an independent non-executive director, with effect from 1 December 2024.

 

Deborah Davis

 

Deborah spent her executive career in Sales, Marketing, Customer experience and Operations at some of the world's largest technology businesses including senior roles at PayPal, eBay, Symantec and Verizon Business. She holds an engineering honours degree in Applied Science (Electronics) from the University of Melbourne, a Masters degree in Science Management with Distinction from London Business School and is a Chartered Director (CDir).

 

Deborah is on the board of two listed companies, as Chair of diagnostic data and analytics company Diaceutics plc and Remuneration Committee Chair and Non-executive Director of consumer credit company International Personal Finance plc. She is also a Non-executive Director of Lloyds Banking Group Insurance/Scottish Widows Insurance Limited and was formerly a Non-executive Director of The Institute of Directors and of Norwegian listed biometrics company IDEX Biometrics ASA. She is also a trustee of the Southern African Conservation Trust.

 

James Peggie

 

James Peggie will step down from the Board and the Audit, Nomination and Remuneration Committees with effect from the conclusion of the 2024 AGM. James has been on the Board of Sirius since November 2012, and has been an outstanding steward of the Company, having overseen its transformation from an AIM-listed £60 million market capitalisation company to the £1.3 billion FTSE 250 and SAPY-indexed company it is today. During his tenure, James was Senior Independent Director for five years, chair of Sirius' Remuneration Committee for six years and also stood in twice as Board Interim Chair.

 

Commenting on the Board changes, Daniel Kitchen, Chair of Sirius Real Estate, said: "Deborah has impressive credentials as a respected board member across a range of listed, private and social enterprise organisations. She specifically brings a wealth of experience in growth, change and digital transformation in some of the largest technology companies in the world and will provide valuable insights as we continue to develop the use of technology in our business parks and our operating platform, as well as with helping us optimise our impact on society. We are confident that Deborah will be a valuable addition to our Board.

James has made an outstanding contribution to the Board during his tenure which started in 2012 when the company was a £60 million AIM-listed company. He has acted as Senior Independent Director, Interim Board Chair, chair of the Remuneration Committee and as a Member of the Audit and Nomination Committees. We thank him for his incredible support to the Company and the management team over the last 12 years."

The announcement has been made in accordance with requirements of the Listing Rule 9.6.11R of the Listing Rules published by the Financial Conduct Authority (the "Listing Rules") and paragraph 3.59 of the JSE Limited ("JSE") Listings Requirements.

For the purposes of LR 9.6.13R of the Listing Rules and paragraph 3.59 of the JSE Listings Requirements, Deborah Davis is currently a non-executive director of Diaceutics plc and International Personal Finance plc and was in the past five years a non-executive director of IDEX Biometrics ASA.

No further disclosures are required under LR 9.6.13R of the Listing Rules and paragraph 3.59 of the JSE Listings Requirements with respect to this appointment.

Deborah Davis and any 'persons closely associated' with her, have no beneficial interest in the Company's ordinary shares of no par value as at the date of this announcement. 

ENDS

For further information:

Sirius Real Estate

Andrew Coombs, CEO / Chris Bowman, CFO

+49 (0) 30 285010110

 

FTI Consulting (Financial PR)

Richard Sunderland / James McEwan / Talia Shirion / Millie James

+44 (0) 20 3727 1000

SiriusRealEstate@fticonsulting.com 

 

NOTES TO EDITORS

About Sirius Real Estate

Sirius is a property company listed on the main and premium market of the London Stock Exchange and the main board of the JSE. It is a leading owner and operator of branded business and industrial parks providing conventional space and flexible workspace in Germany and the U.K. As of 30 September 2023, the Group's portfolio comprised 139 assets let to 9,248 tenants with a total book value of over €2 billion, generating a total annualised rent roll of €184.2 million. Sirius also holds a 35% stake in Titanium, its €350+ million German-focused joint venture with clients of AXA IM Alts.

 

The Company's strategy centres on acquiring business parks at attractive yields and integrating them into its network of sites - both under the Sirius and BizSpace names and alongside a range of branded products. The business then seeks to reconfigure and upgrade existing and vacant space to appeal to the local market via intensive asset management and investment and may then choose to refinance or dispose of assets selectively once they meet maturity, to release capital for new investment. This active approach allows the Company to generate attractive returns for shareholders through growing rental income, improving cost recoveries and capital values, and enhancing returns through securing efficient financing terms.

 

For more information, please visit: www.sirius-real-estate.com

 

Follow us on LinkedIn at https://www.linkedin.com/company/siriusrealestate/

 

Follow us on X (Twitter) at @SiriusRE

 

 

 

JSE Sponsor

PSG Capital

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUBVSRSAUVUAR
Date   Source Headline
14th Apr 20207:00 amRNSTrading Update and Notice of Full Year Results
2nd Apr 20209:30 amRNSTotal Voting Rights
1st Apr 20208:00 amRNSNotice of Trading Update
27th Mar 20203:50 pmRNSDealing In Securities By Employee Benefit Trust
26th Mar 202012:00 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSSirius Real Estate Covid-19 update
20th Mar 20202:15 pmRNSDirector/PDMR Shareholding
19th Mar 20204:41 pmRNSSecond Price Monitoring Extn
19th Mar 20204:36 pmRNSPrice Monitoring Extension
11th Mar 20203:25 pmRNSHolding(s) in Company
6th Mar 20201:20 pmRNSHolding(s) in Company
5th Mar 20207:00 amRNSSirius completes debut Schuldschein issuance
27th Jan 202012:10 pmRNSDirector/PDMR Shareholding
23rd Jan 20208:30 amRNSHolding(s) in Company
14th Jan 202012:15 pmRNSSecond scrip allotment
10th Jan 20202:00 pmRNSAllotment of Scrip Dividend
6th Jan 20207:00 amRNSSirius acquires two business parks for EUR33.4m
2nd Jan 20207:00 amRNSTotal Voting Rights
19th Dec 201911:00 amRNSInterim report posted to shareholders and NSM
19th Dec 201911:00 amRNSCash fraction applicable to the Scrip Dividend
17th Dec 20197:00 amRNSCompletion of acquisition
10th Dec 20193:20 pmRNSDirector/PDMR Shareholding
2nd Dec 20191:00 pmRNSScrip Dividend Announcement
2nd Dec 20197:00 amRNSSirius acquires office complex near Munich Airport
28th Nov 20199:30 amRNSHolding(s) in Company
25th Nov 20197:00 amRNSHalf-year Report
11th Nov 20197:30 amRNSHolding(s) in Company
6th Nov 20197:30 amRNSHolding(s) in Company
31st Oct 20193:15 pmRNSHolding(s) in Company
23rd Oct 20197:00 amRNSAppointment of Company Secretary
22nd Oct 201910:00 amRNSHolding(s) in Company
2nd Oct 20197:00 amRNSTrading Update and Extension of Banking Facility
1st Oct 20193:30 pmRNSTotal Voting Rights
13th Sep 20197:00 amRNSHolding(s) in Company
6th Sep 20194:20 pmRNSHolding(s) in Company
4th Sep 20194:00 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSCompletes acquisition of 2nd Bochum property
28th Aug 20193:00 pmRNSDirector/PDMR Shareholding
27th Aug 20193:04 pmRNSDirector/PDMR Shareholding
22nd Aug 20194:15 pmRNSAdmission of Scrip Shares & Update re Scrip Circ.
14th Aug 201911:15 amRNSAllotment of Scrip Dividend
1st Aug 201911:45 amRNSSirius completes jv with AXA Investment Managers
29th Jul 20194:50 pmRNSResult of Annual General Meeting
26th Jul 20191:00 pmRNSSirius notarises two acquisitions
22nd Jul 20192:30 pmRNSHolding(s) in Company
11th Jul 20194:15 pmRNSHolding(s) in Company
11th Jul 20199:30 amRNSCash fraction applicable to the Scrip Dividend
8th Jul 20193:30 pmRNSHolding(s) in Company
8th Jul 20193:30 pmRNSHolding(s) in Company
5th Jul 20199:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.